Last update 08 May 2025

KATP channels x SUR x HMGCR

Basic Info

Related Targets
KATP channelsSURHMGCR

Related

1
Drugs associated with KATP channels x SUR x HMGCR
Atorvastatin Calcium Hydrate/Glimepiride
Target
HMGCR x KATP channels x SUR
Mechanism
HMG-CoA reductase inhibitors [+2]
Active Org.-
Originator Org.
GSK PlcGSK Plc
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with KATP channels x SUR x HMGCR
NCT01495013
/ CompletedPhase 3
Study ATG115317, a Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
100 Clinical Results associated with KATP channels x SUR x HMGCR
Login to view more data
100 Translational Medicine associated with KATP channels x SUR x HMGCR
Login to view more data
0 Patents (Medical) associated with KATP channels x SUR x HMGCR
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free